{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:52:22Z","timestamp":1784951542336,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"am","delay-in-days":269,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00dcB\u0130TAK","doi-asserted-by":"publisher","award":["120Z586"],"award-info":[{"award-number":["120Z586"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017302","name":"Barbara Ann Karmanos Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejmech.2025.117890","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T18:57:11Z","timestamp":1750359431000},"page":"117890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Anti-cancer efficacy of novel lonidamine derivatives: Design, synthesis, in vitro, in vivo, and computational studies targeting hexokinase-2"],"prefix":"10.1016","volume":"296","author":[{"given":"\u04e6zgecan","family":"\u015eavlu\u011f \u0130pek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0957-6965","authenticated-orcid":false,"given":"Bilgesu Onur","family":"Sucu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Selvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulya","family":"Koksalar Alkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fc\u015fra","family":"Tiryaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilmi Kaan","family":"Alkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Sayyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130layda","family":"Tolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"G\u00fczel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Durda\u011f\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuri","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Korkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117890_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","article-title":"Current cancer epidemiology","volume":"9","author":"Mattiuzzi","year":"2019","journal-title":"J. Epidemiol. Glob. Health"},{"key":"10.1016\/j.ejmech.2025.117890_bib2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.21037\/jtd.2017.02.75","article-title":"Cancer prevention from the perspective of global cancer burden patterns","volume":"9","author":"Nagai","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.ejmech.2025.117890_bib3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s40495-022-00289-6","article-title":"The effectiveness of various chemotherapeutic agents in cancer treatment","volume":"8","author":"Kashifa Fathima","year":"2022","journal-title":"Curr. Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2025.117890_bib4","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1093\/annonc\/mdu444","article-title":"Association between treatment toxicity and outcomes in oncology clinical trials","volume":"25","author":"Abola","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejmech.2025.117890_bib5","doi-asserted-by":"crossref","DOI":"10.1200\/JOP.2012.000623","article-title":"Appropriate chemotherapy dosing for obese adult patients with cancer: American society of clinical oncology clinical practice guideline","volume":"8","author":"Griggs","year":"2012","journal-title":"J. Oncol. Pract."},{"key":"10.1016\/j.ejmech.2025.117890_bib6","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2025.117890_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2025.117890_bib8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s13187-013-0486-9","article-title":"Mini-review on glycolysis and cancer","volume":"28","author":"Akram","year":"2013","journal-title":"J. Cancer Educ."},{"key":"10.1016\/j.ejmech.2025.117890_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4062\/biomolther.2017.184","article-title":"Cancer energy metabolism: shutting power off cancer factory","volume":"26","author":"Kim","year":"2018","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.ejmech.2025.117890_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2013.85","article-title":"Cancer cell metabolism: implications for therapeutic targets","volume":"45","author":"Jang","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117890_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jons.2017.06.002","article-title":"Biology of glucose metabolization in cancer cells","volume":"3","author":"Fadaka","year":"2017","journal-title":"J. Oncol. Sci."},{"key":"10.1016\/j.ejmech.2025.117890_bib12","article-title":"A pan-cancer analysis of the role of hexokinase II (HK2) in human tumors","volume":"12","author":"Li","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117890_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccr.2013.06.014","article-title":"Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer","volume":"24","author":"Patra","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2025.117890_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/1533033819871306","article-title":"The roles of HK2 on tumorigenesis of cervical cancer","volume":"18","author":"Liu","year":"2019","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.ejmech.2025.117890_bib15","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1158\/1535-7163.MCT-07-0115","article-title":"Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma","volume":"6","author":"Kim","year":"2007","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2025.117890_bib16","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1016\/j.bmcl.2014.09.041","article-title":"An update on therapeutic opportunities offered by cancer glycolytic metabolism","volume":"24","author":"Granchi","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117890_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104511","article-title":"Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy","volume":"150","author":"Abdel-Wahab","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.117890_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-019-1865-3","article-title":"Inhibition of hexokinases holds potential as treatment strategy for rheumatoid arthritis","volume":"21","author":"Song","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejmech.2025.117890_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103146","article-title":"Synthesis of novel methyl jasmonate derivatives and evaluation of their biological activity in various cancer cell lines","volume":"91","author":"Sucu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117890_bib20","series-title":"Recent Studies on Lonidamine, the Lead Compound of the Antispermatogenic indazol-carboxylic Acids","author":"Gatto","year":"2002"},{"key":"10.1016\/j.ejmech.2025.117890_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10042-1","article-title":"Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117890_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2017.01.139","article-title":"Targeting hexokinase II as a possible therapy for cholangiocarcinoma","volume":"484","author":"Thamrongwaranggoon","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2025.117890_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135114","article-title":"Synthesis of novel hybrid lonidamine-coumarin derivatives and their anticancer activities","volume":"1281","author":"Ipek","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117890_bib24","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1042\/BCJ20160068","article-title":"Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine","volume":"473","author":"Bhutia","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2025.117890_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbcan.2016.08.001","article-title":"Mechanism of antineoplastic activity of lonidamine","volume":"1866","author":"Nath","year":"2016","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.ejmech.2025.117890_bib26","series-title":"Recovery of Response to Adriamycin and Cyclophosphamide by Lonidamine in Previously Treated Metastatic Breast Cancer Patients","author":"Tomirotti","year":"1993"},{"key":"10.1016\/j.ejmech.2025.117890_bib27","series-title":"Lonidamine Significantly Increases the Activity of Epirubicin in Patients with Advanced Breast Cancer: Results from a Multicenter Prospective Randomized Trial","author":"Dogliotti","year":"1996"},{"key":"10.1016\/j.ejmech.2025.117890_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2025.117890_bib29","author":"Mondal"},{"key":"10.1016\/j.ejmech.2025.117890_bib30","article-title":"A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease","volume":"12","author":"Kau","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejmech.2025.117890_bib31","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41416-018-0076-z","article-title":"Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma","volume":"118","author":"Orecchioni","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2025.117890_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14979","article-title":"Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade","volume":"8","author":"Ouzounova","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117890_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2024.10.002","article-title":"Hexokinase 2 senses fructose in tumor-associated macrophages to promote colorectal cancer growth","author":"Yan","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejmech.2025.117890_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09015-1","article-title":"Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model","volume":"10","author":"Piranlioglu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117890_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.immuni.2017.12.014","article-title":"Activation of p53 in immature myeloid precursor cells controls differentiation into Ly6c+CD103+ monocytic antigen-presenting cells in tumors","volume":"48","author":"Sharma","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2025.117890_bib36","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bmcl.2016.12.062","article-title":"Structure-activity relationship study and discovery of indazole 3-carboxamides as calcium-release activated calcium channel blockers","volume":"27","author":"Bai","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117890_bib37","doi-asserted-by":"crossref","first-page":"81817","DOI":"10.1039\/C5RA15191K","article-title":"Novel potent HIF-1 inhibitors for the prevention of tumor metastasis: discovery and optimization of 3-aryl-5-indazole-1,2,4-oxadiazole derivatives","volume":"5","author":"Sheng","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117890_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2191-2858-2-8","article-title":"Synthesis and evaluation of substituted diphenyl-1,3,4-oxadiazole derivatives for central nervous system depressant activity","volume":"2","author":"Singh","year":"2012","journal-title":"Org. Med. Chem Lett."},{"key":"10.1016\/j.ejmech.2025.117890_bib39","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.bmcl.2012.01.063","article-title":"Novel TIPP (H-Tyr-Tic-Phe-Phe-OH) analogues displaying a wide range of efficacies at the \u03b4 opioid receptor. Discovery of two highly potent and selective \u03b4 opioid agonists","volume":"22","author":"Berezowska","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117890_bib40","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.3987\/COM-12-12565","article-title":"Design, synthesis and biological activity evaluation of 2,5-diphenyl-1,3,4-oxadiazole derivatives as novel inhibitors of fructose-1,6-bisphosphatase","volume":"85","author":"He","year":"2012","journal-title":"Heterocycles"},{"key":"10.1016\/j.ejmech.2025.117890_bib41","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1021\/jo1023393","article-title":"Rapid synthesis of 1,3,5-substituted 1,2,4-triazoles from carboxylic acids, amidines, and hydrazines","volume":"76","author":"Castanedo","year":"2011","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117890_bib42","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.bmcl.2018.03.025","article-title":"Evaluation of analogues of furan-amidines as inhibitors of NQO2","volume":"28","author":"Alnabulsi","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117890_bib43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bioorg.2018.11.045","article-title":"3D-QSAR assisted identification of FABP4 inhibitors: an effective scaffold hopping analysis\/QSAR evaluation","volume":"84","author":"Floresta","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117890_bib44","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all-atom protein loop prediction, proteins: structure, Function and Genetics","volume":"55","author":"Jacobson","year":"2004","journal-title":"Proteins: Struct. Funct. Bioinfor."},{"key":"10.1016\/j.ejmech.2025.117890_bib45","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/ct100578z","article-title":"PROPKA3: consistent treatment of internal and surface residues in empirical p K a predictions","volume":"7","author":"Olsson","year":"2011","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2025.117890_bib46","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117890_bib47","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1021\/acs.jctc.1c00136","article-title":"Reliable and accurate solution to the induced fit docking problem for protein-ligand binding","volume":"17","author":"Miller","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2025.117890_bib48","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117890_bib49","series-title":"SC Conference","first-page":"43","article-title":"bowers2006","author":"Bowers","year":"2006"},{"key":"10.1016\/j.ejmech.2025.117890_bib50","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1021\/j100308a038","article-title":"The missing term in effective pair potentials","volume":"91","author":"Berendsen","year":"1987","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.ejmech.2025.117890_bib51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/00268977200100031","article-title":"NpT-ensemble monte carlo calculations for binary liquid mixtures","volume":"23","author":"McDonald","year":"1972","journal-title":"Mol. Phys."},{"key":"10.1016\/j.ejmech.2025.117890_bib52","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jcc.20292","article-title":"Integrated modeling program, applied chemical theory (IMPACT","volume":"26","author":"Banks","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.117890_bib53","series-title":"Inhibitors of Hexokinase and Methods of Use Thereof","author":"Mjalli","year":"2016"},{"key":"10.1016\/j.ejmech.2025.117890_bib54","unstructured":"Software - spectral instruments imaging, (n.d.).https:\/\/spectralinvivo.com\/software\/?utm_term=spectral%20imaging%20systems&utm_campaign=%5BSearch%5D%5BBrand%5D&utm_source=adwords&utm_medium=ppc&hsa_acc=7526384108&hsa_cam=9256954923&hsa_grp=93999832756&hsa_ad=433511019826&hsa_src=g&hsa_tgt=kwd-899184626040&hsa_kw=spectral%20imaging%20systems&hsa_mt=p&hsa_net=adwords&hsa_ver=3&gad_source=1&gclid=CjwKCAjw_4S3BhAAEiwA_64Yhl5WTSm6nacnPtzUIQJf-fU84EXwNTyMa_nsMSDp_jRTZjTJ5962ZBoC2KcQAvD_BwE (accessed December 16, 2024)."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:14:11Z","timestamp":1762265651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425006555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":54,"alternative-id":["S0223523425006555"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117890","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-cancer efficacy of novel lonidamine derivatives: Design, synthesis, in vitro, in vivo, and computational studies targeting hexokinase-2","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117890"}}